Hiroaki Nagano
- Oncology top 2%
- Surgery top 5%
- Molecular Biology
- Epidemiology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Hidetoshi EguchiMorito MondenKeizo DonoMasato SakonKoji UmeshitaShoji NakamoriAtsushi MiyamotoShigeru Marubashi
- Topics
- Pancreatic and Hepatic Oncology Research (28 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers)Hepatocellular Carcinoma Treatment and Prognosis (17 papers)
- Cited by
- HepatologyOncologySurgery
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroaki Nagano
84 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 115
- Oncology 1.0k
- Surgery 986
- Molecular Biology 614
- Epidemiology 598
- Pulmonary and Respiratory Medicine 548
Countries citing papers authored by Hiroaki Nagano
This map shows the geographic impact of Hiroaki Nagano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nagano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nagano more than expected).
Fields of papers citing papers by Hiroaki Nagano
This network shows the impact of papers produced by Hiroaki Nagano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nagano. The network helps show where Hiroaki Nagano may publish in the future.
Co-authorship network of co-authors of Hiroaki Nagano
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Nagano. A scholar is included among the top collaborators of Hiroaki Nagano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Nagano. Hiroaki Nagano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 6 | |
| 5 | 6 | |
| 6 | 8 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 15 | |
| 10 | 5 | |
| 11 | 7 | |
| 12 | 6 | |
| 13 | 203 | |
| 14 | 133 | |
| 15 | 8 | |
| 16 | 19 | |
| 17 | 98 | |
| 18 | 10 | |
| 19 | 43 | |
| 20 | 1 |
About Hiroaki Nagano
Hiroaki Nagano is a scholar working on Hepatology, Oncology and Cancer Research, having authored 88 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (28 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Hepatocellular Carcinoma Treatment and Prognosis (17 papers). The work is most often cited by research in Hepatology (451 citations), Oncology (1.0k citations) and Surgery (986 citations). Hiroaki Nagano has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hidetoshi Eguchi, Morito Monden, Keizo Dono, Masato Sakon, Koji Umeshita, Shoji Nakamori, Atsushi Miyamoto, Shigeru Marubashi, Yutaka Takeda and Shoichi Hazama. Their work appears in journals such as Journal of Clinical Oncology, Hepatology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.